ADAG
Price
$2.22
Change
+$0.03 (+1.37%)
Updated
Aug 28 closing price
Capitalization
104.63M
96 days until earnings call
TNFA
Price
$0.06
Change
-$0.03 (-33.33%)
Updated
Aug 28 closing price
Capitalization
873.74K
Interact to see
Advertisement

ADAG vs TNFA

Header iconADAG vs TNFA Comparison
Open Charts ADAG vs TNFABanner chart's image
Adagene
Price$2.22
Change+$0.03 (+1.37%)
Volume$44.54K
Capitalization104.63M
TNF Pharmaceuticals
Price$0.06
Change-$0.03 (-33.33%)
Volume$129.97M
Capitalization873.74K
ADAG vs TNFA Comparison Chart in %
Loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAG vs. TNFA commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Buy and TNFA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ADAG: $2.22 vs. TNFA: $0.06)
Brand notoriety: ADAG and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 43% vs. TNFA: 187%
Market capitalization -- ADAG: $104.63M vs. TNFA: $873.74K
ADAG [@Biotechnology] is valued at $104.63M. TNFA’s [@Biotechnology] market capitalization is $873.74K. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, TNFA is a better buy in the long-term than ADAG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 8 TA indicator(s) are bullish while TNFA’s TA Score has 4 bullish TA indicator(s).

  • ADAG’s TA Score: 8 bullish, 3 bearish.
  • TNFA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ADAG is a better buy in the short-term than TNFA.

Price Growth

ADAG (@Biotechnology) experienced а -2.63% price change this week, while TNFA (@Biotechnology) price change was -17.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

ADAG is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADAG($105M) has a higher market cap than TNFA($874K). ADAG YTD gains are higher at: 11.558 vs. TNFA (-94.643). TNFA has higher annual earnings (EBITDA): -8.35M vs. ADAG (-29.17M). ADAG has more cash in the bank: 62.8M vs. TNFA (5.88M). TNFA has less debt than ADAG: TNFA (2.68K) vs ADAG (6.85M). ADAG has higher revenues than TNFA: ADAG (103K) vs TNFA (0).
ADAGTNFAADAG / TNFA
Capitalization105M874K12,014%
EBITDA-29.17M-8.35M349%
Gain YTD11.558-94.643-12%
P/E RatioN/AN/A-
Revenue103K0-
Total Cash62.8M5.88M1,068%
Total Debt6.85M2.68K255,788%
FUNDAMENTALS RATINGS
TNFA: Fundamental Ratings
TNFA
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGTNFA
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSIOF3.85N/A
+0.09%
kneat.com, Inc.
AMDUF80.95N/A
N/A
AMUNDI SA
RNSHF43.53N/A
N/A
Renishaw Plc
SFCO9.55N/A
N/A
Southern Financial Corp.
TTHG0.13-0.01
-6.07%
Titanium Holdings Group, Inc.

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and TNFA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and TNFA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
+1.37%
TNFA - ADAG
26%
Poorly correlated
-31.56%
NEVPF - ADAG
25%
Poorly correlated
N/A
IBO - ADAG
23%
Poorly correlated
+1.30%
QTTB - ADAG
23%
Poorly correlated
+2.91%
CYBN - ADAG
22%
Poorly correlated
-0.39%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with ARTV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
-31.56%
ARTV - TNFA
47%
Loosely correlated
-3.36%
COGT - TNFA
39%
Loosely correlated
-2.34%
PHAT - TNFA
39%
Loosely correlated
-0.64%
TVGN - TNFA
36%
Loosely correlated
-1.88%
LRMR - TNFA
32%
Poorly correlated
+0.26%
More